![Patrick James Doyle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick James Doyle
President at KINEMED INC
Patrick James Doyle active positions
Companies | Position | Start | End |
---|---|---|---|
KINEMED INC | Director/Board Member | 21/05/2014 | - |
President | 21/05/2014 | - | |
Stelexis Therapeutics LLC
![]() Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Chief Executive Officer | - | - |
Career history of Patrick James Doyle
Former positions of Patrick James Doyle
Companies | Position | Start | End |
---|---|---|---|
Ipsen Bioinnovation Ltd.
![]() Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | President | 31/07/2006 | - |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | 31/12/1994 | - |
Roche Ltd.
![]() Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Corporate Officer/Principal | - | - |
CYMABAY THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Training of Patrick James Doyle
University of Sunderland | Doctorate Degree |
University of Geneva | Graduate Degree |
Statistics
International
United States | 6 |
United Kingdom | 3 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 3 |
President | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
Ipsen Bioinnovation Ltd.
![]() Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
CymaBay Therapeutics, Inc.
![]() CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Roche Ltd.
![]() Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Finance |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
KineMed, Inc.
![]() KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services KineMed, Inc. develops and commercializes biomarker platform technology. It provides dynamic proteomics platform, a functionally interpretable systems biology platform. The company was founded by David M. Fineman and Marc K. Hellerstein in February 2001 and is headquartered in Emeryville, CA. | Commercial Services |
Stelexis Therapeutics LLC
![]() Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Health Technology |
- Stock Market
- Insiders
- Patrick James Doyle
- Experience